- News & Education
Pfizer Inc. (PFE) reported its Q4 financial results before the market open on Wall Street on Tuesday.
The world’s third largest pharmaceutical company reported total revenue of $23.838 billion in the previous quarter (105% increase from the same period in 2020), falling short of analyst forecast of $24.157 billion.
Earnings per share reported at $1.08 (152% increase from the same period in 2020) vs. $0.87 per share expected.
Dr. Albert Bourla, Chairman and CEO, outlined the work the company has done against COVID-19 over the past two years following the latest financial results: ”In the early days of the COVID-19 pandemic, we committed to use all of the resources and expertise we had at our disposal to help protect populations globally against this deadly virus, as well as to offer treatments to help avoid the worst outcomes when infections do occur. We put billions of dollars of capital on the line in pursuit of those goals, not knowing whether those investments would ever pay off. Now, less than two years since we made that commitment, we are proud to say that we have delivered both the first FDA-authorized vaccine against COVID-19 (with our partner, BioNTech) and the first FDA-authorized oral treatment for COVID-19.”
”These successes have not only made a positive difference in the world, but I believe they have fundamentally changed Pfizer and its culture forever. Everywhere I look in the company, I see colleagues who are inspired by what we have achieved to date and filled with determination to be part of the next breakthrough that could change the world for patients in need. As we enter a new year, I look forward to all we will accomplish together,” Dr. Bourla added.
Pfizer Inc. (PFE) chart (Weekly)
Shares of Pfizer fell during the trading day on Tuesday, down by around 3% at $51.37 per share. Here is how the stock has performed in the past year –
Pfizer is the 28th largest company in the world, with a total market cap of $ 282.77 billion.
You can trade Pfizer Inc. (PFE) and many other stocks from the NYSE, NASDAQ, HKEX and the ASX with GO Markets as a Share CFD.
Sources: Pfizer Inc., TradingView, CompaniesMarketCap
Disclaimer: Articles are from GO Markets analysts and contributors and are based on their independent analysis or personal experiences. Views, opinions or trading styles expressed are their own, and should not be taken as either representative of or shared by GO Markets. Advice, if any, is of a ‘general’ nature and not based on your personal objectives, financial situation or needs. Consider how appropriate the advice, if any, is to your objectives, financial situation and needs, before acting on the advice. If the advice relates to acquiring a particular financial product, you should obtain and consider the Product Disclosure Statement (PDS) and Financial Services Guide (FSG) for that product before making any decisions.